Li L, Ge Z, Zhang D, Kuang J, Ma X, & Jiang S. (2017). Efficacy and safety of quadruple therapy including tirofiban in the treatment of Chinese NSTE-ACS patients failing to receive timely percutaneous coronary intervention. Dove Medical Press.
Chicago Style (17th ed.) CitationLi L, Ge Z, Zhang D, Kuang J, Ma X, and Jiang S. Efficacy and Safety of Quadruple Therapy Including Tirofiban in the Treatment of Chinese NSTE-ACS Patients Failing to Receive Timely Percutaneous Coronary Intervention. Dove Medical Press, 2017.
MLA (9th ed.) CitationLi L, et al. Efficacy and Safety of Quadruple Therapy Including Tirofiban in the Treatment of Chinese NSTE-ACS Patients Failing to Receive Timely Percutaneous Coronary Intervention. Dove Medical Press, 2017.
Warning: These citations may not always be 100% accurate.